Simplified production of a recombinant human angiostatin derivative that suppresses intracerebral glial tumor growth

Clinical Cancer Research

Volumn 5, Issue 11, 1999, Pages 3689-3694

  Meneses, Patricio I ^a   Abrey, Lauren E ^b   Hajjar, Katherine A ^a   Gultekin, S Humayun ^b   Duvoisin, Robert M ^a   Berns, Kenneth I ^c   Rosenfeld, Myrna R ^a,d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF ARKANSAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSTATIN; RECOMBINANT HUMAN ANGIOSTATIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; GLIOMA; GROWTH INHIBITION; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; RAT;

ANIMALS; BRAIN NEOPLASMS; CELL DIVISION; CELL LINE; CELLS, CULTURED; CLONING, MOLECULAR; ENDOTHELIUM, VASCULAR; FEMALE; GLIOMA; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS; TRANSFECTION; UMBILICAL VEINS;

EID: 0032713943     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328, 1994.
2. Gately, S., Twardowski, P., Stack, M. S., Cundiff, D. L., Grella, D., Castellino, F. J., Enghild, J., Kwaan, H. C., Lee, F., Kramer, R. A., and Soff, G. A. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor, angiostatin. Proc. Natl. Acad. Sci. USA, 94: 10868-10872, 1997.
3. Pezzella, M. Drug giant turns back on cancer phenom. Biotechnology Newswatch, 2: 13-14, 1999.
4. Griscelli, F., Li, H., Bennaceur-Griscelli, A., Soria. J., Opolon, P., Soria, C., Perricaudet, M., Yeh, P., and Lu, H. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. USA, 95: 6367-6372, 1998.
5. Tanaka, T., Cao, Y., Folkman, J., and Fine, H. A. Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA. Cancer Res., 58: 3362-3369, 1998.
6. Sim, B. K. L., O'Reilly, M. S., Liang, H., Fortier, A. H., He, W., Madsen, J. W., Lapcevich, R., and Nacy, C. A. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res., 57: 1329-1334, 1997.
7. Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S. G., O'Reilly, M. S., Llinas, M., and Folkman, J. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem., 271: 29461-29467, 1996.
8. Brem, S., Cotran, R., and Folkman, J. Tumor angiogenesis: a quantitative method for histologie grading. J. Natl. Cancer Inst., 48: 347-356, 1972.
9. Leon, S. P., Folkerth, R. D., and Black, P. M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer (Phila.), 77: 362-372, 1996.
10. Maxwell, M., Naber, S. P., Wolfe, H. J., Hedley-Whyte, E. T., Galanopoulos, T., Neville-Golden, J., and Antoniades, H. N. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res., 51: 1345-1351, 1991.
11. Paulus, W., Grothe, C., Sensenbrenner, M., Janet, T., Baur, I., Graf, M., and Roggendorf, W. Localization of basic fibroblast growth factor, a mitogen and angiogenic factor, in human brain tumors. Acta Neuropathol., 79: 418-423, 1990.
12. Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D., and Risau, W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer, 59: 520-529, 1994.
13. Takahashi, J. A., Fukumoto, M., Igarashi, K., Oda, Y., Kikuchi, H., and Hatanaka, M. Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg., 76: 792-798, 1992.
14. Murphy, P. R., Sato, Y., and Knee, R. S. Phosphorothioate antisense oligonucleotides against basic fibroblast growth factor inhibit anchorage-dependent and anchorage-independent growth of a malignant glioblastoma cell line. Mol. Endocrinol., 6: 877-884, 1992.
15. Morrison, R. S. Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. J. Biol. Chem., 266: 728-734, 1991.
16. Redekop, G. J., and Naus, C. C. Transfection with bFGF sense and antisense cDNA resulting in modification of malignant glioma growth. J. Neurosurg., 82: 83-90, 1995.
17. Stan, A. C., Nemati, M. N., Pietsch, T., Walter, G. F., and Dietz, H. In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor. J. Neurosurg., 82: 1044-1052, 1995.
18. Begemann, M., Kashimawo, S. A., Choi, Y. A., Kim, S., Christiansen, K. M., Duigou, G., Mueller, M., Schieren, I., Ghosh, S., Fabbro, D., Lampen, N. M., Heitjan, D. F., Schiff, P. B., Bruce, J. N., and Weinstein, I. B. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter. Clin. Cancer Res., 2: 1017-1030, 1996.
19. Pinski, J., Schally, A. V., Halmos, G., Szepeshazi, K., and Groot, K. Somatostatin analogues and bombesin/gastrin-releasing peptide antagonist RC-3095 inhibit the growth of human glioblastomas in vitro and in vivo. Cancer Res., 54: 5895-5901, 1994.
20. Hajjar, K. A., Hamel, N. M., Harpel, P. C., and Nachman, R. L. Binding of tissue plasminogen activator to cultured human endothelial cells. J. Clin. Invest., 80: 1712-1719, 1987.
21. Graham, F. L., and van der Eb, A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology, 52: 456-467, 1973.
22. Kirsch, M., Strasser, J., Allende, R., Bello, L., Zhang, J., and Black, P. M. Angiostatin suppresses malignant glioma growth in vivo. Cancer Res., 58: 4654-4659, 1998.
23. Lucas, R., Holmgren, L., Garcia, I., Jimenez, B., Mandriota, S. J., Boriat, F., Sim, B. K., Wu, Z., Grau, G. E., Shing, Y., Soff, G. A., Bouck, N., and Pepper, M. S. Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood, 92: 4730-4741, 1998.
24. Wiman, B., and Wallen, P. The specific interaction between plasminogen and fibrin. A physiological role of the lysine binding site in plasminogen. Thromb. Res., 10: 213-222, 1977.
25. Lerch, P. G., Rickli, E. E., Lergier, W., and Gillessen, D. Localization of individual lysine-binding regions in human plasminogen and investigations on their complex-forming properties. Eur. J Biochem 107: 7-13, 1980.
26. Horak, E., Leek, R., Klenk, N., LeJeune, S., Smith, K., Stuart, N., Greenall, M., Stepniewska, K., and Harris, A. L. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as an indicator of node metastasis and survival in breast cancer. Lancet, 340: 1120-1124, 1992.
27. Folkman, J. How is blood vessel growth regulated in normal and neoplastic tissue? Cancer Res., 46: 467-473, 1986.
28. Bicknell, R., and Harris, A. L. Mechanisms and therapeutic implications of angiogenesis. Curr. Opin. Oncol., 8: 60-65, 1996.
29. Hsu, S. C., Volpert, O. V., Steck, P. A., Mikkelsen, T., Polverini, P. J., Rao, S., Chou, P., and Bouck, N. P. Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res., 56: 5684-5691, 1996.
30. Joseph, I. B., Vukanovic, J., and Isaacs, J. T. Antiangiogenic treatment with linomide as chemoprevention for prostate, seminal vesicle, and breast carcinogenesis in rodents. Cancer Res., 56: 3404-3408, 1996.
31. Schmidek, H. H., Nielsen, S. L., Schiller, A. L., and Messer, J. Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J. Neurosurg., 34: 335-340, 1971.
32. Asai, A., Miyagi, Y., Sugiyama, A., Gamanuma, M., Hong, S. H., Takamoto, S., Nomura, K., Matsutani, M., Takakura, K., and Kuchino, Y. Negative effects of wild-type p53 and s-Myc on cellular growth and tumorigenicity of glioma cells. Implication of the tumor suppressor genes for gene therapy. J. Neuro-oncol., 19: 259-268, 1994.
33. von Deimling, A., Eibl, R. H., Ohgaki, H., Louis, D. N., von Ammon, K., Petersen, I., Kleihues, P., Chung, R. Y., Wiestler, O. D., and Seizinger, B. R. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52: 2987-2990, 1992.
34. Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H-J., De Tribolet, N., and Cavenee, W. K. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet., 8: 171-176, 1994.
35. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996.
36. Ghazizadeh, S., Carroll, J. M., and Taichman, L. B. Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy. J. Virol., 71: 9163-9169, 1997.
37. Rother, R. P., Fodor, W. L., Springhorn, J. P., Birks, C. W., Setter, E., Sandrin, M. S., Squinto, S. P., and Rollins, S. A. A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J. Exp. Med., 182: 1345-1355, 1995.
38. Sparer, T. E., Wynn, S. G., Clark, D. J., Kaplan, J. M., Cardoza, L. M., Wadsworth, S. C., Smith, A. E., and Gooding, L. R. Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype. J. Virol., 71: 2277-2284, 1997.
39. Le Gal La Salle, G., Robert, J. J., Berrard, S., Ridoux, V., StratfordPerricaudet, L. D., Perricaudet, M., and Mallet, J. An adenovirus vector for gene transfer into neurons and glia in the brain. Science (Washington DC), 259: 988-990, 1993.
40. Yang, Y., and Wilson, J. M. Clearance of adenovirus-infected hepatocytes by MHC class I-restricted CD4+ CTLs in vivo. J. Immunol., 155: 2564-2570, 1995.
41. Udelsman, R., Chen, H., Loman, K., Pitt, H. A., and Saudek, C. D. Implanted programmable insulin pumps: one hundred fifty-three patient years of surgical experience. Surgery, 122: 1005-1011, 1997.
42. Saudek, C. D. Novel forms of insulin delivery. Endocrinol. Metab. Clin. North Am., 26: 599-610, 1997.
43. Fine, H. A., Dear, K. B., Loeffler, J. S., Black, P. M., and Canellos, G. P. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer (Phila.), 71: 2585-2597, 1993.
44. Prados, M. D., and Russo, C. Chemotherapy of brain tumors. Semin. Surg. Oncol., 14: 88-95, 1998.